GAPDH and malaria: The phage display approach led to the identification of a peptide that structurally mimics glyceraldehyde-3-phosphate dehydrogenase (GAPDH) on the surface of Plasmodium sporozoites; this peptide became a new vaccine candidate for targeting malaria liver invasion (Cha et al., 2016, 2018).